All about Akkermansia

This product is free for DIFM DPG members.

This webinar was presented live on March 5, 2024.

Akkermansia muciniphila is on the forefront of microbiome research, touted for its ability to strengthen gut barrier function and produce health-promoting short chain fatty acids. Learn from Dr. Adam Perlman about the emerging science linking Akkermansia to healthy weight, intestinal integrity, GLP-1, and how these can be applied in clinical practice to support patient health and longevity.

Sponsored by: Pendulum

CPE Level: 2
CPEU: 1

Performance Indicators

• 8.1.1 Interprets and applies evidence-based literature and standards for determining nutritional needs of target audiences.
• 8.1.4 Integrates knowledge of macro- and micronutrients for digestion, absorption and metabolism throughout the lifespan in practice.
• 8.2.3 Analyzes new information and how it impacts medical nutrition therapy.

Learning Objectives

• Understand the role that Akkermansia plays in overall gut health and homeostasis.
• Be familiar with clinical outcomes related to the role Akkermansia plays in aging, metabolic health, and food cravings.
• Learn key protocols to address Akkermansia in clinical practice.

Speaker

Adam Perlman, MD, MPH

Dr. Adam Perlman, Chief Medical Officer at Pendulum Therapeutics, formerly served as the Director of Integrative Health and Wellbeing at Mayo Clinic, Florida and Medical Director for Employee Wellbeing. Prior to that, he was Associate Vice President for Health and Wellness for the Duke University Health System.

Dr. Perlman received his BA from Tufts University and his MD from Boston University School of Medicine, completing residencies in Internal Medicine and Preventive Medicine as well as a General Internal Medicine Research Fellowship at Boston Medical Center. He earned an MPH from the Boston University School of Public Health.